Bharat Biotech’s Covaxin may get Emergency Use List approval soon, here’s what WHO said | India News
New Delhi: The decision to include Bharat Biotech's COVID-19 vaccine Covaxin in World Health Organization's (WHO) emergency use list (EUL) ...
New Delhi: The decision to include Bharat Biotech's COVID-19 vaccine Covaxin in World Health Organization's (WHO) emergency use list (EUL) ...
PTI, New Delhi Published by: Sanjeev Kumar Jha Updated Sat, 10 Jul 2021 05:09 PM IST While addressing a webinar ...
The World Health Organization (WHO) is likely to take a decision on including Bharat Biotech’s Covid-19 vaccine Covaxin in the ...
The World Health Organization (WHO) is likely to take a decision on including Bharat Biotech's COVID-19 vaccine ...
Press24 News Bureau, New Delhi. Published by: Jeet Kumar Updated Fri, 09 Jul 2021 06:30 AM IST Scientists of NIV ...
Coronavirus News LIVE Updates: Bharat Biotech, a global leader in vaccine development and innovation, announced today the safety and efficacy analysis ...
New Delhi: The Bharat Biotech on Saturday (July 3, 2021) released the results from the Phase 3 trials of Covaxin ...
New Delhi: The Bharat Biotech on Saturday (July 3, 2021) released the results from the Phase 3 trials of Covaxin ...
World Health Organization Chief Scientist Soumya Swaminathan told NDTV on Thursday that the decision on emergency approval for ...
New DelhiIndia has asked the member countries of the European Union (EU) to include Covishield and Covaccine in the Green ...
The European Union (EU) has eased travel restrictions under its 'Green Pass' scheme, while India has urged the 27 member ...
New Delhi: As the European Union relaxes travel restrictions under its 'Green Passport' scheme, India has requested the members of ...
Image for representation. (Image source: Reuters)Only those inoculated with exempted vaccines will be allowed to travel within the EU during ...
New Delhi: Shortly after Brazil announced suspending a USD 324 million Covaxin contract that has mired President Jair Bolsonaro in accusations ...
World Desk, Press24 News, Brasilia Published by: Deepti Mishra Updated Wed, 30 Jun 2021 12:55 PM IST The company has ...
Hyderabad: The Brazilian government, which had earlier agreed to purchase 20 million doses of Bharat Biotech’s COVID-19 vaccine Covaxin, on ...
Highlights:US approves big claim on Indian corona vaccine covaccineThe American organization NIH said that the vaccine is also effective on ...
Meanwhile, the US National Institute of Health has said that India’s Covaxin, developed by Bharat Biotech in collaboration with the ...
New Delhi: The National Institutes of Health (NIH), a part of the US Department of Health and Human Services, on ...
According to an affidavit filed by the Centre in the Supreme Court, Bharat Biotech has not begun supply for a ...
Highlights:Covishield and Covaccine effective on all variants of corona virus - GovernmentIndian vaccines are also effective against alpha, beta, gamma ...
New Delhi: In what may be one of the youngest vaccination beneficiary yet in Uttar Pradesh, a 2 year and ...
West Bengal: Mamata Banerjee during poll campaign. Banerjee claimed that Covaxin has also created problems with neighbouring Bangladesh and Brazil.PTI ...
Alarmed by Delta Plus Cases in Maharashtra, Kerala and MP, Centre Issues 3-point AdvisoryUnion Health Ministry on Tuesday advised Maharashtra, ...
New Delhi: Covaxin, India’s first indigenous COVID-19 vaccine, is expected to be available for children by September, Delhi AIIMS chief ...
NEW DELHI: Bharat Biotech’s anti-COVID vaccine Covaxin has shown 77.8 per cent efficacy in phase 3 data trial data reviewed ...
File photo of Bharat Biotech's Covaxin.Covaxin's Phase 3 trial data which has shown 77.8% efficacy was approved by the Subject ...
New Delhi , June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator ...
The trial data is crucial as it will provide details of the efficacy of the vaccine, which was developed in ...
Highlights:Bharat Biotech gave data of Phase III trial of Covaccine to DCGIThe emergency use of covaccine was approved on January ...
New Delhi: Senior AAP leader Atishi on Saturday (June 19) said that two days of Covaxin and 14 days of ...
Maharashtra on Thursday reported 9,830 fresh COVID-19 cases and 236 fatalities and also added 400 old deaths, taking its infection ...
New Delhi: The Hyderabad-based Bharat Biotech`s pre-submission meeting has been scheduled on June 23 for evaluation of the World Health ...
Highlights:Congress party has told that Sonia Gandhi has got the vaccine, but Rahul has notrahul gandhi got infected with corona ...
New DelhiA new controversy has started after Bharat Biotech's reply to RTI regarding Corona Vaccine and Gaurav Pandhi, Coordinator of ...
The central government is likely to renegotiate the price at which it currently procures Covishield and Covaxin from their manufacturers, ...
Hyderabad/DelhiBharat Biotech's corona vaccine 'Covaccine' has suffered a setback in the US. US drug regulator USFDA has rejected Ocugen's application ...
Ocugen, the US partner of Bharat Biotech claimed the company will now be seeking full approval of Covaxin. Disclaimer: ...
New Delhi: Senior Aam Aadmi Party (AAP) leader and MLA Atishi released the vaccination bulletin on Wednesday and stated that ...
New Delhi: Bharat Biotech, the Hyderabad-based COVID vaccine manufacturer, on Wednesday (June 9, 2021) said that the company is going ...
There is a growing concern among Indians who have a taken the Covaxin jab whether it would be recognised for ...
NEW DELHI: Bharat Biotech, the Hyderabad-based COVID vaccine manufacturer, has categorically rejected a recent study that claimed that Covaxin is ...
New DelhiBharat Biotech has announced the fourth phase trial of its vaccine after objecting to a recent study on the ...
Hyderabad-based vaccine manufacturer Bharat Biotech will conduct phase 4 trials of Covaxin to check the real-world effectiveness of the vaccine. ...
New Delhi: The government on Tuesday (June 8) set the maximum price private hospitals can charge for the three COVID-19 ...
New Delhi Private hospitals will not be able to charge exorbitant prices for the corona vaccine. The central government has ...
News Desk, Press24 News, New Delhi Published by: Sanjeev Kumar Jha Updated Tue, 08 Jun 2021 09:37 PM IST The ...
The Centre on Tuesday announced revised prices of Covid-19 vaccines for private hospitals, fixing Covishield shot at Rs 780, Covaxin ...
AIIMS Director Dr Randeep Guleria has resolved all the doubts of the people amidst the assumptions and questions regarding the ...
New Delhi: The Centre has accorded a security cover of armed CISF commandos for the Hyderabad premises of Bharat Biotech, ...
These 44 crore doses of COVID-19 vaccines will be delivered by their makers between August and December 2021, the Union ...
Warning of severe symptoms, Pune’s National Institute of Virology has found a new Covid-19 variant — B.1.1.28.2 — through genome ...
For the first time in the country, two separate studies have come to the fore regarding fungus and vaccine. Of ...
New Delhi: The All India Institute of Medical Sciences (AIIMS), Delhi will start screening children for clinical trials of indigenous ...
Indian health care workers who were administered Covishield have shown better antibody response than the Covaxin recipients, ...
New DelhiThe Delhi government on Sunday directed private hospitals and nursing homes to administer the vaccine only to those taking ...
DDMA Delhi government on Sunday (June 6) directed private hospitals and nursing homes to administer Covaxin only to those eligible ...
The All India Institute of Medical Sciences (AIIMS) in Delhi plans to begin clinical trials of Bharat Biotech’s Covid-19 vaccine ...
Representational image. REUTERSCovaxin trials for its pediatric dose are being conducted on children of 2-17 age groups. CNN-News18 New DelhiLast ...
Data sharing is going on with WHO to give recognition to Bharat Biotech's Covaxin, the government said, ...
New Delhi: Hyderabad-based Bharat Biotech on Thursday (June 3, 2021) said that biopharmaceutical company Ocugen Inc will have exclusive co-development, ...
America’s top infectious disease specialist Dr Anthony Fauci on Thursday said the US is eager to involve Indian investigators in ...
New Delhi: After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is also planning to start the ...
News Desk, Press24 News, Patna Published by: Deepti Mishra Updated Thu, 03 Jun 2021 07:59 AM IST Clinical trial of ...
New Delhi: All India Institute of Medical Sciences (AIIMS), Patna has started paediatric trials of Bharat Biotech’s Covaxin. Bharat Biotech ...
New Delhi: The Delhi High Court on Wednesday (June 2) said if the Delhi government could not ensure that people ...
News Desk, Press24 News, New Delhi Published by: Sanjeev Kumar Jha Updated Tue, 01 Jun 2021 06:16 PM IST NITI ...
Highlights:Decline in cases of corona under treatment in 30 states since last weekInfection rate of Kovid-19 cases in 344 districts ...
AAP MLA Atishi (Image: PTI)While the vaccination of the 18-44 years age group remained suspended for the sixth day, she ...
Indian Immunologicals Ltd, a city-based facility under the National Dairy Development Board, has announced its plans to begin the production ...
New Delhi: Senior Aam Aadmi Party leader Atishi on Friday (May 28, 2021) said that even for the fifth consecutive ...
New Delhi: The central government on Friday (May 28) said that reports claiming Bharat Biotech producing 6 crore Covaxin doses ...
Acting on the direction of the Haryana government, the Gurugram district administration on Friday ordered all the private hospitals to ...
Kerala has hit a Covaxin wall which is now threatening the Covid-19 inoculation drive especially for those above 45 years ...
India administered about 2.1 crore Covaxin doses till Thursday morning, official data shows. However, according to a report in the ...
Lucknow: During the ongoing COVID-19 vaccination in Uttar Prdaesh's Siddharthnagar district, a major negligence by health workers has been reported. ...
New Delhi: The Indian Council of Medical Research (ICMR) will commence a study to examine the effectiveness of AstraZeneca's Covishield ...
The incident was reported from Badhni Primary Health Care Centre, Uttar Pradesh. Chief Medical Officer of the district has ordered ...
Bharat Biotech has supplied its Covid-19 vaccine Covaxin to 30 cities in India within 30 days, a top company official ...
New York / GenevaThe World Health Organization (WHO) has said that more information needs to be obtained from Bharat Biotech, ...
Meanwhile, the UN on Monday declared the world “at war” against Covid-19, as India’s death toll passed 300,000 and Japan ...
New Delhi: A key meeting between Bharat Biotech's MD Dr V Krishna Mohan, other officials of the Hyderabad based pharma ...
Highlights:Children between the ages of two to 18 years will be 'tried'Children's clinical trial of covaxin may begin in June'Bharat ...
Hyderabad-based vaccine maker Bharat Biotech in April expanded its Covaxin-manufacturing capacity to 500 million doses a year, ...
New Delhi: In a recent development, a study conducted by Clinical Infectious Diseases in collaboration with National Institute of Virology ...
Highlights:Bihar is also involved in the trial of Covaxine on children.Bharat Biotech will start in Patna AIIMSTrial can start at ...
Bharat Biotech will establish a manufacturing unit for the production of Covaxin covid-19 vaccine in Maluru industrial area of ...
New Delhi: Amid a political war of words between the Centre and the Delhi government over the availability of ...
New Delhi: The Niti Aayog member (Health) Dr VK Paul on Thursday (May 13, 2021) outlined the central government’s ...
New Delhi: Amid a political war of words between the Centre and the Delhi government over the availability of ...
Highlights:Many teachers and students have also fallen ill in the second wave of Corona.After many mutations of the virus has ...
The Centre on Thursday rejected the Delhi government’s claim that Covaxin maker Bharat Biotech has refused to provide it ...
New DelhiCorona vaccination is taking place all over the country, but there is a huge shortage of vaccines at the ...
The second batch of Russia’s Sputnik V vaccine will arrive in India on May 14, after the first batch ...
An expert panel of the government recommended on Thursday that the gap between two doses of the Covishield vaccine ...
New Delhi: A government panel has recommended a gap of at least 12-16 weeks between two doses of the ...
New Delhi: The Drugs Controller General of India (DCGI) has given its approval to Bharat Biotech to start conducting ...
Highlights:Only nine days stock of Covishield vaccine left in DelhiThe center intervened and asked for the vaccine dose to be ...
Lucknow: As states face an acute shortage of COVID-19 vaccines, the central government on Wednesday (May 12, 2021) approved ...
Highlights:There is now a lack of vaccine in the capital Delhi.Second dose of covaxine can be started after four to ...
People in the 18-44 age group won't be able to get Covaxin shots in Delhi from Thursday as Deputy ...
To ramp up the vaccination drive and meet the high demand of doses, production of Covaxin will soon begin ...
New Delhi: The Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin has got the necessary approval from an expert panel for ...
West Bengal’s daily tally of new COVID-19 cases breached the 20,000-mark on Tuesday, while 132 more people died in ...
New DelhiIn the fight against the corona epidemic in the country, now children can get good news in the coming ...
covaxin Delhi has run out of Covaxin stock for people in the 18-44 age group and will have to ...
Delhi has run out of Covaxin stock for people in the 18-44 age group and will ...
The Bombay High Court has permitted Biovet Private Limited, an associate company of Bharat Biotech, to take possession of ...
New DelhiAam Aadmi Party (AAP) leader Atishi said on Monday that if the vaccines were not supplied, the Delhi government ...
New Delhi: Delhi Health Minister Satyendar Jain on Monday (May 10) said Delhi has only one day's Covaxin stock left and ...
Mumbai: Vaccination centres in Mumbai did not administer Covaxin for the second consecutive day on Monday (May 1) because ...
New Delhi: As soon as the Centre announced the third phase of COVID-19 vaccination, under which people aging above ...
The Centre supplied just 36,000 doses of Covaxin to Maharashtra on Sunday despite the state health department urging the ...
The Madurai Bench of Madras High Court on Friday questioned the Central government why Covaxin, the ...
File photo of Bharat Biotech's Covaxin.The study found the two-dose vaccine significantly boosted the antibody and neutralising efficacy against ...
The government is exploring the possibility of producing Bharat Biotech’s Covid vaccine Covaxin abroad through a technology transfer between ...
New Delhi: Bharat Biotech on Thursday (April 29) slashed the rates of its COVID-19 vaccine 'Covaxin' to Rs 400 ...
Washington: Covaxin, India's home-grown COVID-19 vaccine, has been found to neutralise the 617 variant of the deadly virus, White ...
Covaxin, India's home-grown COVID-19 vaccine, has been found to neutralise the 617 variant of the deadly ...
Image of Covaxin and Covishield vaccines. The two vaccines show "milder" illness in case of infection post vaccination, a ...
New Delhi: Uttar Pradesh Chief Minister Yogi Adityanath has placed an order for 50 lakh doses of both the ...
New Delhi: Bharat Biotech has written to the India's drug regulator seeking extension of the shelf-life of its indigenously ...
zeenews.india.com understands that your privacy is important to you and we are committed for being transparent about the technologies ...
Bharat Biotech has introduced the prices for its Covid-19 vaccine, Covaxin, while laying out the distribution guidelines to the ...
Bharat Biotech will sell its Covaxin vaccine against the coronavirus to state governments at Rs 600 per dose and ...
New Delhi: Bharat Biotech on Saturday (April 24) announced that it will provide its COVID-19 vaccine Covaxin to all ...
Bharat Biotech’s Covaxin has shown an overall efficacy of 78 per cent against Covid-19 and 100 per ...
Covaxin, a vaccine developed by Bharat Biotech, has demonstrated overall interim clinical efficacy of 78 per cent and 100 ...
Union Health Minister Harsh Vardhan on Sunday said there will be a 10 times rise in Covaxin vaccine production ...
On the other hand, Maharashtra logged 67,123 coronavirus cases on Saturday in its biggest single-day spike since the start ...
New Delhi: Union Health Minister Dr Harsh Vardhan on Friday (April 16) announced that the production of Covaxin will ...
The Centre on Friday said it will accelerate the development and production of indigenous Covid-19 vaccines under its Atmanirbhar ...
The Union government has given its permission to the city-based Haffkine Institute to manufacture Covaxin, an anti-coronavirus vaccine of ...
Image for representation.The hospital authorities informed the Jaipur chief medical and health officer about the theft on Tuesday night ...
Russia’s Sputnik V, the world’s first vaccine registered against the coronavirus disease (Covid-19), has been recommended for emergency use ...
Bharat Biotech is likely to increase the production of its Covid-19 vaccine, Covaxin, to 12 million doses from the ...
Prime Minister Narendra Modi gets his second dose of the Covid-19 vaccine at AIIMS, Delhi.Modi has taken Covaxin, India's ...
Mexico’s health regulator Cofepris has authorized the emergency use of India’s COVID-19 vaccine COVAXIN, Mexican Foreign Minister Marcelo Ebrard ...
Image for representation.The ex DCGI permitted Bharat Biotech to give a third dose of Covaxin to a few volunteers ...
Image of Covaxin and Covishield vaccines. Bhargava further said that mutations are sporadic and single mutations are not found ...
New Delhi: The Centre on Tuesday (March 30, 2021) announced that the two COVID-19 vaccines Covishield and Covaxin are ...
Nepal on Friday gave emergency authorisation to India’s COVID-19 vaccine COVAXIN, becoming only the third country to approve the ...
The Brihanmumbai Municipal Corporation on Friday said both Oxford-AstraZeneca’s vaccine Covishield and Bharat Biotech’s Covaxin are equally effective and ...
The need to change the composition of Covaxin has not been felt yet in view of good efficacy of ...
Ocugen Inc plans to sell 100 million doses of COVAXIN, developed by Bharat Biotech and backed by state-run ICMR, ...
Bharat Biotech’s Covaxin has been given the regular emergency use authorisation in public interest, putting it on ...
New Delhi: Bharat Biotech's COVID-19 vaccine, Covaxin, will no longer have to carry the 'clinical trial mode' label, NITI ...
The Centre on Thursday said Bharat Biotech's indigenously developed Covaxin is out of the "clinical trial mode" and that ...
Covid-19 vaccine: Bharat Biotech's Covaxin goes off clinical trial mode Bharat Biotech’s Covaxin on Wednesday got ...
Bharat Biotech’s Covid-19 vaccine Covaxin can be granted Emergency Use Approval, Drug regulator’s Subject Expert Committee (SEC) has recommended ...
A day after Bharat Biotech announced 81 percent efficacy for Covaxin, a news report stated that India’s first indigenously ...
A UK government spokesman said on Thursday that the Serum Institute “is one part of our supply chain for ...
After facing questions for providing emergency approval to Bharat Biotech’s Covaxin without vaccinating enough participants in its phase 3 ...
Here is a comparison between the two COVID-19 vaccines – Covishield and Covaxin - approved in India. Disclaimer: ...
New Delhi: Bharat Biotech on Wednesday announced the phase 3 results of its coronavirus vaccine ‘Covaxin’on Wednesday claiming the ...
New Delhi: As part of the global COVAX initiative, the African country of Rwanda received its first batch of ...
Announcing phase three results of coronavirus vaccine ‘Covaxin’, Bharat Biotech on Wednesday said that the indigenous shots have demonstrated ...
Bharat Biotech's homegrown Covid-19 vaccineç Covaxin, has shown an interim vaccine efficacy of 81% in late-stage ...
Coronavirus LIVE Updates: Covax, a scheme designed to ensure poorer countries do not miss out on vaccinations, is aiming ...
New Delhi: India on Monday (March 1, 2021) woke up to the surprising news of Prime Minister Narendra Modi ...
Coronavirus LIVE Updates: PM Modi Takes First Dose of Covaxin; Co-WIN Server Crashes, Issues Reported as India Rushes to ...
Coronavirus live updates: India's count of active cases has jumped to 170,293. On Sunday, the country registered 15,616 fresh ...
New Delhi, Feb 26: The process technology developed by the Council Of Scientific and Industrial ResearchIndian Institute Of Chemical ...
New Delhi: Bharat Biotech on Friday announced that it will supply 20 million doses of its COVID-19 vaccine 'Covaxin' ...
Bharat Biotech International Ltd on Friday confirmed that it has signed an agreement with Brazil for supply of 20 ...
Locals who recalled hearing it back in December said they scrambled to take up the offer -- 750 rupees ...
Hyderabad: A high-power delegation from Ukraine led by its Health Minister Dr Maksym Stepanov visited the Bharat Biotech facilities ...
Krishna Ella, chairman and managing director of Bharat Biotech, said the company would come out with the ...
Allaying concerns of Chhattisgarh over incomplete phase 3 trials of Covaxin, Union Health Minister Harsh Vardhan on Thursday said ...
Hyderabad: Bharat Biotech, which has received a government purchase order for the supply of 55 lakh doses of Covaxin, ...
Covaxin has been developed by Hyderabad-based Bharat Biotech. (File photo)Covaxin, indigenously developed by Bharat Biotech, has got approval for ...
New Delhi: After the alleged death of a volunteer enrolled in Bharat Biotech`s Covaxin clinical trial in Bhopal, the ...
Ecuador's ambassador to India Hector Cueva Jacome. (ANI)Jacome revealed to news agency ANI that he participated in the Phase-3 ...
NEW DELHI: Union Health Minister Harsh Vardhan on Thursday said that the COVID-19 vaccines 'Covishield' and 'Covaxin' are on ...
NEW DELHI: Bharat Biotech, which has jointly developed Covaxin with the ICMR, has sought to dispel rumours and claimed ...
Jan 05, 2021 08:21 AM IST Daybreak 'Won't Hurt Anyone, Carried Out 200% Honest Trials': Bharat Biotech Top Boss ...
Some healthcare experts Monday questioned the government's assertion that Bharat Biotech's COVID-19 vaccine Covaxin can target mutated coronavirus strains ...
Representative image/ReutersDenying allegations that the citybased vaccine maker lacks data of Covaxin, Krishna Ella, chairman of Bharat Biotech, said ...
Hyderabad-based Bharat Biotech has sent the first batch of its Covid vaccine, Covaxin, to the government for further distribution ...
New Delhi: Zee News reporter Pooja Makkar on Monday (January 4) became the first female journalist to get coronavirus ...
New Delhi: A day after the news of two COVID-19 vaccines getting a nod for the restricted use went ...
New Delhi: A day after the news of two COVID-19 vaccines getting a nod for the restricted use went ...
New Delhi: Union Health Minister Harsh Vardhan on Sunday (January 3, 2020) called it a 'watershed moment in India's ...
Bharat Biotech on Sunday said the approval for emergency use of its Covid-19 vaccine --Covaxin -- ...
NEW DELHI: Several ministers and political leaders on Sunday (January 3) welcomed India's decision to give emergency use authorisation ...
Senior Congress leader Shashi Tharoor on Sunday said that the emergency approval to COVID-19 vaccine--Covaxin is ...
Senior Congress leaders on Sunday raised concerns over India's drugs regulator granting permission for restricted use of Bharat Biotech's ...
In a significant development, the Drug Controller General of India (DCGI) on Sunday (January 2) formally approved Serum Institute ...
In a significant development, Drugs Controller General of India (DCGI) on Sunday (January 3) formally approved Oxford-AstraZeneca's Covishield and ...
Bharat Biotech on Saturday said it is moving towards achieving the target of having 26,000 volunteers ...
The recommendation for Bharat Biotech's vaccine came a day after the panel cleared the Serum Institute of India's emergency ...
Bharat Biotech on Saturday announced successful recruitment of 23,000 volunteers, and continued progress towards achieving the goal of 26,000 ...
New Delhi: The COVID-19 vaccine developed by Bharat Biotech and ICMR (Indian Council of Medical Research) has been approved ...
Over 750 volunteers have beenadministered the first dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' as part ...
Ahmedabad: Over 750 volunteers have been administered the first dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' as part of ...
Hyderabad: Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on Vice-President M ...
NEW DELHI: The Indian Council of Medical Research (ICMR) has said that the Indian vaccine against COVID-19, Covaxin, has ...
New Delhi: The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday (December 24) invited ...
Hyderabad: City-based pharma giant Bharat Biotech has announced successful recruitment of 13,000 volunteers, and continued progress towards achieving the ...
New Delhi: Bharat Biotech on Tuesday announced recruitment of 13,000 volunteers and continued progress towards achieving the goal of ...
Nearly 70 volunteers were given Covaxin, a vaccine being developed indigenously for coronavirus, in the Phase III trials here, ...
Press24News is venture of Kotgari News & Media Network (KNMN). Kotgari News Network working as news & media agency across India & abroad
© 2021 Press24 News English - Kotgari News & Media Network Press24 News.Traffic Bot
© 2021 Press24 News English - Kotgari News & Media Network Press24 News.Traffic Bot